Delivery Order SPE2DB20D3103-SPE2DB23FM6X1
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a ceiling value of $79,844.36 and a completion date of December 20, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $1,397.16 and is a firm fixed-price delivery order with a completion date of May 16, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,655.10, is for the delivery of 4567923870 LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,650.26, is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,361.68 firm-fixed-price contract is for the supply of 4565683812 - LIDOCAINE 5% PATCH 30S. The contract has a completion date of September 5, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for the provision of a broad range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567869185 LIDOCAINE 5% PATCH 30S, with a ceiling value of $2,025.96 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a ceiling value of $2,797.32 and a period of performance through May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,920.83, is for the supply of LIDOCAINE 5% PATCH 30S, a medical product. The contract has an ultimate completion date of May 13, 2024. It is a firm fixed-price contract and does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,128.36 contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a completion date of September 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to federal agencies, and this award is part of the company's extensive Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,558.02, is for the delivery of 4567691174 ! LIDOCAINE 5% PATCH 30S, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 26, 2025. AmerisourceBergen Drug Corp is a for-profit organization that specializes in distributing a wide range of pharmaceutical products and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM6X1Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,933.86, is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of March 9, 2023 and is a firm fixed price type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare facilities worldwide. This delivery order is part of that larger IDC contract vehicle. The contract was awarded on an unrestricted basis with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/8/23 |